Industry Sponsored Symposia
Click here to download the Programme
Thursday, June 29, 2017
| 12:00 – 13:00 | Industry Session: Progression of Chronic Venous Disease: Where are we today?(Supported by an educational grant from Servier)
Chairperson(s): Armando Mansilha, Andre Van Rij |
Archive Room |
| 12:00 | Evolution of chronic venous disease. Update of epidemiological data. Armando Mansilha |
|
| 12:15 | Pathophysiology of progression of chronic venous disease. Andre Van Rij | |
| 12:30 | Therapeutic options to delay the progression. Marc Vuylsteke | |
| 12:45 | Panel Discussion | |
| 13:00 – 14:00 | Lunch and Visit to Exhibition | Exhibition Hall |
| 14:00 – 15:00 | Industry Session: The value of Glycosaminoglycan in Venous Disease(Supported by an educational grant from Alfa Wassermann)
Chairperson(s): Jaweed Fareed, Frederico Bastos Goncalves |
Archive Room |
| 14:00 | Pleiotropic activities that affect multiple sites of venous disease. Ferdinando Mannello |
|
| 14:20 | Review of clinical trials on the reduction of symptoms and ulcer healing. Tomasz Urbanek |
|
| 14:40 | Prevention of recurrent deep venous thrombosis as the key to preventing post-thrombotic syndrome. Andrew Nicolaides |
Friday, June 30, 2017
| 11:00 – 12:00 | Industry Session: New Data on Chronic Venous Disease, New Place for Cyclo 3(Supported by an educational grant from Pierre Fabre)
Chairperson(s): Arkadiusz Jawien, Armando Mansilha |
Archive Room |
| 11:00 | Effects of venotonic drugs on the microcirculation: Comparison between ruscus extract and diosmine. Eliete Bouskela | |
| 11:15 | Cyclo 3. New clinical meta analysis. Stavros Kakkos | |
| 11:30 | Guidelines Update. Andrew Nicolaides | |
| 11:45 | Discussion. Arkadiusz Jawien, Armando Mansilha |